WeVote
Log In

Bill

Bill

HB 5270

AN ACT PROHIBITING DIRECT-TO-CONSUMER PRESCRIPTION DRUG ADVERTISEMENTS.

2025 Regular Session Introduced by Dave Rutigliano

Connecticut bill HB 5270 bans pharmaceutical companies from directly advertising prescription drugs to consumers, aiming to reduce unnecessary prescriptions and healthcare costs.

REF. TO JOINT COMM. ON General Law
#advertising #drugs
0
WeVote Research Nonpartisan
Bill Summary · HB 5270

Legislative bill overview

HB 5270 would ban direct-to-consumer (DTC) prescription drug advertisements in Connecticut, preventing pharmaceutical companies from marketing prescription medications directly to patients through television, print, digital, and other media channels. This would align Connecticut with the vast majority of developed nations, as only the United States and New Zealand currently permit such advertising. The bill applies specifically to prescription drugs, not over-the-counter medications.

Why is this important

DTC pharmaceutical advertising significantly influences healthcare spending and consumer behavior—Americans spend roughly $9.6 billion annually on prescription drugs advertised directly to them, and studies show these ads increase demand for advertised medications regardless of medical necessity. By restricting DTC ads, the bill aims to reduce unnecessary prescriptions, lower healthcare costs, and potentially decrease medication-related harms. The policy represents a fundamental shift in how prescription drugs can be marketed within the state.

Potential points of contention

  • Free speech concerns: Pharmaceutical companies argue DTC advertising constitutes protected commercial speech; opponents counter that healthcare regulation justifies limitations
  • Patient information vs. industry profit: Supporters claim ads inform patients; critics argue ads prioritize sales over medical evidence and often minimize side effects
  • Economic impact: The pharmaceutical and advertising industries would face reduced revenue; supporters argue savings in healthcare costs offset this loss
  • Enforceability: Questions remain about how Connecticut would regulate advertisements from out-of-state companies and digital platforms

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.